Amgen Cuts Repatha Price: Direct-to-Consumer Sales Arrive
Update: 2025-10-06
Description
Big Pharma shakeup! Amgen slashes the price of its cholesterol drug Repatha by 60% for uninsured customers, selling directly to consumers for $239 a month. Is this the future of affordable medication, or just a way to dodge insurance companies? Find out how this move, driven by political pressure and a partnership with GoodRx, could revolutionize how you buy prescriptions and save you money, especially if you're paying out-of-pocket.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
